118 related articles for article (PubMed ID: 30722710)
1. Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer.
Bozkaya Y; Yazıcı O
Expert Rev Mol Diagn; 2019 Mar; 19(3):267-272. PubMed ID: 30722710
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
[TBL] [Abstract][Full Text] [Related]
3. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
4. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
Bozkaya Y; Kurt B; Gürler F
Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
7. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
8. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
9. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
Bozkaya Y; Köstek O; Sakin A; Özyükseler DT; Şakalar T; Çil İ
Support Care Cancer; 2020 May; 28(5):2273-2282. PubMed ID: 31471631
[TBL] [Abstract][Full Text] [Related]
10. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
12. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
15. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
[TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.
Xiao Y; Yang H; Lu J; Li D; Xu C; Risch HA
BMC Cancer; 2019 Oct; 19(1):1020. PubMed ID: 31664937
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
